A branch of medical imaging known as "Molecular Imaging" focuses on capturing images of molecules in living patients that are relevant to medicine. This contrasts with traditional techniques like histopathology for extracting molecular information from preserved tissue samples. The molecules of interest might either be those generated naturally by the body or those that a doctor injects into a patient that were created artificially in a lab. The procedure of injecting a contrast agent—such as a microbubble, metal ion, or radioactive isotope—into a patient's bloodstream and then using an imaging modality to monitor its movement within the body—such as ultrasound, MRI, CT, or PET—is the most typical example of molecular imaging used in clinical practise today. The desire to comprehend fundamental biological processes led to the development of molecular imaging in the area of radiology. The science of radiology developed molecular imaging as a non-invasive way to better comprehend basic molecular processes inside of living things. The ultimate objective of molecular imaging is the non-invasive real-time monitoring of all the biochemical activities taking on inside an organism. Cellular/molecular biology, chemistry, and medical physics are all involved in current molecular imaging research, which is focused on three main areas: 1) developing imaging methods to detect previously undetectable types of molecules; 2) increasing the number and types of contrast agents; and 3) creating functional contrast agents that provide information about the various activities that cells and tissues carry out in both health and disease.
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil